Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Filings indexed 1,382 across all filing types
Latest filing 2014-06-04 AGM Information
Country FR France
Listing PA IPN

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
AGM Information Classification · 99% confidence The document explicitly details the proceedings and outcomes of the 'Ordinary Shareholders' Meeting of IPSEN S.A. held on 4 June 2014'. It mentions the adoption of all resolutions, approval of a dividend distribution, and renewal/appointment of Directors. This content directly relates to the formal business conducted at an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2014-06-04 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
AGM Information Classification · 99% confidence The document is titled "Assemblée Générale Ordinaire des Actionnaires de la société IPSEN S.A. du 4 juin 2014" (Ordinary General Meeting of Shareholders of IPSEN S.A. of June 4, 2014) and explicitly states that "Toutes les résolutions soumises au vote des actionnaires ont été adoptées" (All resolutions submitted to shareholder vote were adopted). It details the approval of a dividend, the renewal of director mandates, and the appointment of a new director. This content is characteristic of materials presented or summarized immediately following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2014-06-04 French
Document availability communications / Preparatory documents for the general meeting
AGM Information Classification · 98% confidence The document explicitly announces the details for an 'Ordinary Shareholders' Meeting' scheduled for June 4, 2014. It mentions the availability of documentation and the notice of meeting, which are key components related to shareholder meetings. This directly aligns with the definition of 'AGM Information' (Code: AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it is an announcement about the meeting, the content is focused on the meeting logistics and documentation availability, making AGM-R the most specific fit over a general RPA or RNS.
2014-05-13 English
Communiqués de mise à disposition de documents / Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document is titled 'Assemblée Générale Ordinaire du 4 juin 2014' (Ordinary General Meeting of June 4, 2014) and discusses the modalities for making preparatory documents available for the meeting. It explicitly mentions the date and location of the AGM and details how shareholders can access the required documents. This content directly relates to the Annual General Meeting (AGM) process. Although it is an announcement about the AGM materials, the primary subject matter is the meeting itself, making 'AGM Information' (AGM-R) the most appropriate classification, as it covers presentations and materials shared during the AGM, or in this case, the notice thereof. Given the short length (3715 chars) and the focus on making documents available, it could also be considered an RPA, but the specific context of the 'Assemblée Générale' strongly points to AGM-R.
2014-05-13 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated May 13, 2014, announcing the resumption of supply for the drug Increlex® in the US following collaboration with the FDA. It details product information, precautions, and company background. This type of announcement, which communicates a specific operational or product update (drug supply resumption) rather than comprehensive financial results (like 10-K or ER), management changes (MANG), or shareholder voting (DVA), typically falls under general regulatory announcements or news releases. Since it is not a standard financial report, a proxy statement, or a specific legal filing, and it is a direct communication to the market about a significant event, it best fits the 'Regulatory Filings' (RNS) category as a general regulatory/market announcement, or potentially a specialized communication if one existed. Given the provided definitions, RNS serves as the best general regulatory announcement fallback for non-standard, material news.
2014-05-13 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated May 13, 2014, announcing a specific operational update regarding the resupply of the drug Increlex® in the U.S. It details product availability, collaboration with the FDA, and provides safety/usage information. This type of announcement, which communicates a specific, non-periodic business event or operational update (like a product supply resolution) that doesn't fit neatly into standard financial reports (10-K, ER, IR), is best classified as a general Regulatory Filing (RNS) or potentially a Regulatory Announcement, as it involves interaction with the FDA regarding supply. Since it is not a formal financial report, a management change, or a dividend notice, RNS serves as the most appropriate general regulatory/corporate announcement category.
2014-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.